Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 4, 2011Clinical Infectious DiseasesOpen Access

Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

View Full Paper
Ask AI
Bookmark
Share

Authors

JIJakko van IngenRadboud University NijmegenRAR.E. AarnoutseRadboud University NijmegenPDP. R. DonaldDesmond Tutu HIV Foundation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ingen et al. (2011) studied this question.

synapsesocial.com/papers/6a768ce4ea35e55311cfef63https://doi.org/10.1093/cid/cir184
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 14 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta‐analysis and Cost‐Effectiveness Study That Focuses on Compliance and Liver Toxicity2009 · 96 citations
  2. 2Tuberculosis Management in the Mid-1970s1976 · 6 citations
  3. 3Rifampin: A Semisynthetic Derivative of Rifamycin-A Prototype for the Future1972 · 69 citations